Topical interferon cream for the treatment of herpes genitalis: a double-blind controlled trial.
Thirty-five women with primary herpes genitalis and 34 women with recurrent herpes genitalis were treated with either placebo, or beta Interferon cream (20,000 iu/g). In comparison with the placebo group, the treatment group showed no benefit in either symptom relief, speed of healing of lesions or length of viral shedding time from lesions.
D000287:Administration, Topical; D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006558:Herpes Genitalis / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D018139:Simplexvirus
D007370:Interferon Type I